2023

9th Annual Statistics Workshop
Applying Statistics and Data Science to Evolving Technical and
Regulatory Paradigm
Hybrid Meeting.h

Novembre, 7-9, 2023
Rockville, USA.

Visit website

The Role of Real-World Evidence for Regulatory and Public Health Decision Making for Accelerated Vaccine Deployment
Hybrid Meeting.h

September, 19-20, 2023
Leuven, Belgium

Visit website

Maintaining the Quality of Vaccines through the Use of References Standards
Hybrid Meeting.h

June, 21-23, 2023
Ottawa, Canada

Visit website

Ethics for CHIM Clinical Trial Protocols Workshop
.

May, 30-31, 2023
Brussels, Belgium

View Agenda

4th Controlled Human Infection Model (CHIM)
Hybrid Meeting

May, 22-24, 2023
Mombasa, Kenya

Visit website

Enabling the Evaluation of COVID-19 Vaccines with Correlates of Protection
A Hybrid Meeting
.
February, 16-17, 2023
Antwerp, Belgium

Visit website

Globally Harmonized Specifications: Current State and Future Opportunities
A Hybrid Meeting
.
January, 10-12, 2023
Basel, Switzerland

Visit website

2022

3Rs implementation in veterinary vaccine batch-release testing: Current state-of-the-art and future opportunities

November 16, 2022
Brussels, Belgium

Visit website

8th Annual IABS Statistics Workshop – Advancing the Impact of CMC Statistics for a New Generation of Statisticians, Scientists, and Modelers

November 7-10, 2022
A virtual Meeting

Visit website

IABS Meeting on High Pathogenicity Avian Influenza Vaccination Strategies to prevent and control HPAI : Removing unnecessary barriers for usages

October 25 – 26, 2022
Paris, France

Visit website

3Rs implementation in veterinary vaccine batchrelease testing: Current state-of-the-art and future opportunities

October 20, 2022
A virtual Meeting

Visit website

3Rs implementation in veterinary vaccine batchrelease testing: Current state-of-the-art and future opportunities

October 6, 2022
A virtual Meeting

Visit website

3rd IABS Next Generation
Sequencing Conference

September 27-28, 2022

Visit website

DCVMN Webinar
Next Generation Sequencing

July 20, 2022
A virtual Meeting

Visit website

IABS BIOASTER
FMT Webinar

May 24 & May 25, 2022
A virtual Meeting

Visit website

IABS Gene Therapy Webinar
Standards for Gene Therapy Viral Vector

March 22, 2022
A virtual Meeting

Visit website

2021

Drive Annual Forum Webinar

November 30, 2021

7th Statistics Workshop
Accelerating Drug Development: How QbD Regulatory Partnerships and Pandemic Learning can Further Expedite Meeting Patient Needs

November 8-11, 2021
A virtual Meeting

Visit website

7th IABS Statistics Workshop
Accelerating Drug Development: How QbD, Regulatory Partnerships, and Pandemic Learning Can Further Expedite Meeting Patient Needs

November 8-11, 2021

Visit website

Autogenous Vaccines Meeting
Quality of Production and Movement in a Common Market

September 14-16, 2021

Munich, Germany

Visit website

Evolution of FMT
Evolution of FMT – From Early Clinical to Standardized Treatments

May 21, 2021
A Virtual Meeting

Visit website

Current Efforts in African Swine Fever Vaccines Webinar

May 6, 2021
A Virtual Seminar and Discussion

Visit website

Human Infection Studies Webinar
Human Infection Studies Considerations on manufacturing of challenge agents-viruses (SARS-CoV-2/COVID-19) and parasites as examples

March 31, 2021
A Joint Wellcome Trust/HIC-Vac, hVIVO and IABS webinar

Visit website

Platform Technology Webinar
Platform Technology: Is it possible to reduce vaccine development time?

February 18, 2021
A virtual Meeting

Visit website

IABS-EU_ZAPI Stakeholders Final Conference

February 4-5, 2021
A virtual Meeting

Visit website

2020

6th Statistics Workshop
Approaches for Improving Statistical Partnership in CMC Development, Manufacturing, and Regulation of Biologicals

November 2-5, 2020
A Virtual Meeting

Visit website

SARS-CoV-2 Webinar-An Update

October 16, 2020
A virtual Meeting

Visit website

SARS-CoV-2 CHIM Webinar

June 23, 2020
A virtual Meeting

Visit website

SARS-CoV-2 Webinar
May 27, 2020

IABS has been asked to organize several webinars in order to share scientific information on SARS-CoV-2.

As science is evolving day after day, it is important for many people to have an overview of the actual knowledge at a specific moment in time.

The first IABS webinar that took place Wednesday May 27th from 14:00-16:00 CEST gave you an insight to what is known about SARS-CoV-2, the epidemiology worldwide, the disease from an immunology viewpoint and where we are today with the development of vaccines against the virus.

This webinar is the first in a series of webinars to inform our network on what is known about the virus, the disease, and how to cope with it.

Visit website

3rd Human Challenge Trials in Vaccine Development
February 6-7, 2020

3rd Human Challenge Trials in Vaccine Development

Visit website

5th Cell Therapy Conference, Tokyo, Japan
February 4-5, 2020

5th IABS Cell Therapy Conference Towards international convergence of basic technical requirements and evaluation of human cell therapy products

Muromachi Mitsui Hall & Conference
Tokyo, Japan – Organized by: International Alliance for Biological Standardization (IABS) With the support from: Osaka University Graduate School of Medicine

Visit website

IABS 65th Anniversary Conference on Infectious Diseases
February 26-28, 2020

New paths for sustainable solutions to tackle global and emerging infectious threats

IABS celebrated its 65th Anniversary on February 26-28, 2020, in Lyon, France.

Visit website

2019

Animal Testing for Vaccines, Bangkok, Thailand

December 3-4, 2019

Animal Testing for Vaccines Implementing Replacement, Reduction and Refinement: Challenges and Priorities

Visit website

2nd Setting Specifications for Biological Products

December 2-3, 2019

2nd Setting Specifications for Biological Products: A Pathway to Harmonization

Visit website

2nd Conference on Next Generation Sequencing for Adventitious Virus Detection in Human and Veterinary Biologics
November 13-14, 2019

2nd Conference on Next Generation Sequencing
for Adventitious Virus Detection in
Human and Veterinary Biologics

An IABS-EU Meeting

Visit website

Quality Requirements for Challenge Agents

October 22, 2019

Quality Requirements for Challenge Agents
An IABS-EU Meeting

Visit website

Towards Rabies Elimination in Asia-Pacific – From Theory to Practice, Bangkok, Thailand

September 25-26, 2019

Towards Rabies Elimination in Asia-Pacific – From Theory to Practice

Visit website

Diagnostics in the Veterinary Field

May 15-17, 2019

Workshop on Diagnostics in the Veterinary Field: The Role in Health Surveillance and Disease Identification

A workshop focusing on advantages / benefits and disadvantages and gaps of the current methods and methodologies

Visit website

2018

Implementing Nonanimal Approaches to Human and Veterinary Vaccine Testing

October 16-17, 2018

Workshop: Implementing Non-animal Approaches to Human and Veterinary Vaccine Testing: Achieving Scientific and Regulatory Success for Rabies and Beyond

National Institutes of Health, Bethesda, Maryland

Visit website

5th Statistical Approaches for CMC Development and Lifecycle Management of Biotherapeutics and Vaccines

November 26-28, 2018

Venue: US Pharmacopeia
Rockville, Maryland

Visit website

Narcolepsy and Pandemic Influenza Vaccination

Mars 26-27, 2018

Narcolepsy and Pandemic Influenza Vaccination: What we know and what we need to know before the next Pandemic

Eurostation II, Place Victor Horta
Brussels, Belgium

In partnership with
Federal Agency for Medicines and Health Products (FAMHP)
Vaccine Center of Excellence

Visit website

4th Cell Therapy Conference

June 5-6, 2018

4th Cell Therapy Conference
Manufacturing and Testing of Pluripotent Stem Cells
Organized by The International Alliance for Biological Standardization – IABS
with support from and in collaboration with the California Institute for Regenerative Medicine – CIRM

Los Angeles, California

Visit website

2017

Autogenous Vaccines and Their Role in Animal Health Strategy

September 25-26, 2017

Autogenous Vaccines and Their Role
in Animal Health Strategy
Venue: Het Pand, University of Ghent
Co-organized by IABS-EU and University of Ghent / PROVAXS

Visit website

Advancing Analytics for Biotechnology Products

November 6-8, 2017

Advancing Analytics for Biotechnology Products
An IABS – FDA international meeting
co-sponsored by NIST
Venue: NIST, Gathersburg, Maryland
Green Auditorium

Gathersburg, Maryland

Visit website

4th Statistical and Data Management Approaches for Biotechnology Drug Development

October 30 – November 1, 2017

4th Statistical and Data Management Approaches for Biotechnology Drug Development
Venue: USP Pharmacopeia, Rockville, Maryland

Visit website

Next Generation Sequencing for Adventitious Virus Detection in Biologics

October 26-27, 2017

Next Generation Sequencing for
Adventitious Virus Detection in BiologicsVenue: USP Pharmacopeia, Rockville, Maryland

Visit website

2nd Human Challenge Trials Conference

September 28-30, 2017

2nd Human Challenge Trials Conference

Venue: Hilton Hotel, Rockville, Maryland

Visit website

2016

Harmonized Safety Monitoring of Immunization Pregnancy

March 29-30, 2016

Harmonized Safety Monitoring of Immunization Pregnancy
International Consensus Conference

National Institutes of Health
Bethesda, Maryland, USA

Visit website

Emerging Diseases in Animals:
Strategies in Surveillance, Control and Eradication

September 28-30, 2016

Co-organized by:
IABS
Paul-Ehrlich-Institut
Hungarian National Food Chain Safety Office

Budapest, Hungary

Visit website

3rd Statistical and Data Management Approaches for Biotechnology Drug Development

October 11-12, 2016

3rd Statistical and Data Management Approaches
for Biotechnology Drug Development

Co-organized by IABS and FDA
USP Headquarters, Rockville, Maryland

Visit website

3rd Conference on Cell Therapy Manufacturing and Testing

November 2-3, 2016

3rd IABS conference on cell therapy
Manufacturing and Testing

This meeting provided an important update on the Regulation and Standardization of Cell Therapies

The Wellcome Collection
London, United Kingdom

Visit website

2015

International Regulatory Endeavour Towards Sound Development of Human Cell Therapy Products

February 18-19, 2015

Venue: Hitotsubashi Hall

Organized by IABS with the support of Pharmaceuticals and Medical devices Agency (PMDA); Japan Science and Technology Agency (JST); National Institute of Biomedical Innovation (NIBIO); World Health Organization (WHO)

Under the auspices of Forum for Innovative Regenerative Medicine (FIRM); Japan Pharmaceutical Manufacturers Association (JPMA); The Japanese Scoiety for Regenerrative Medicine (JSRM)

Tokyo, Japan

Visit website

2nd Statistical and Data Management Approaches for Biotechnology Drug Development

September 29-30, 2015

2nd Statistical and Data Management Approaches for Biotechnology Drug Development

Venue: US Pharmacopeia Conference Center, Rockville, Maryland

Organized by: IABS anad FDA

Visit website

2nd Progress and Challenge in Protein Particles and Immonogenicity of Biotherapeutics

November 12-13, 2015

Venue: US Pharmacopeia Conference Center, Rockville, Maryland

Organized by: IABS and Health Canada

Visit website

2014 Conferences

 Click on the link for all the slides and meeting agenda :

> Human Challenge Trials
> Stats & Data

2020 Replay

Dr. Melanie Saville – SARS-CoV-2 Webinar 

Replay 27/05/2020

Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines:

Presentation: Vaccine development:
Where are we?

Visit website

Dr. Melanie Saville – SARS-CoV-2 Webinar

Replay 16/10/2020

Dr. Melanie Saville, Head of Vaccine R&D, CEPI Vaccines:

Visit website

Prof. Arnaud Marchant – SARS-CoV-2 Webinar

Replay 27/05/2020

Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles

Presentation: Update on SARS-CoV-2 – The disease looked at by the immunologist

Visit website

Prof. Arnaud Marchant – SARS-CoV-2 Webinar

Replay 16/10/2020

Prof. Arnaud Marchant, Director of the Institute for Medical Immunology, Université Libre de Bruxelles

Visit website

Prof. Arnaud Fontanet – SARS-CoV-2 Webinar 

Replay 16/10/2020

Prof. Arnaud Fontanet, Director of the Department of Global Health, Head of the Emerging Diseases Epidemiology Unit, Institut Pasteur

Visit website

Prof. Bruno Lina – SARS-CoV-2 Webinar

Replay 27/05/2020

Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPath
Presentation Title: What do we know about SARS-CoV-2

Visit website

Prof. Bruno Lina – SARS-CoV-2 Webinar

Replay 16/10/2020

Prof. Bruno Lina, professor of Virology, University Claude Bernard Lyon and Director of the research laboratory VirPath

Visit website